ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BGNE BeiGene Ltd

148.85
-5.40 (-3.50%)
May 31 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BeiGene Ltd BGNE NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-5.40 -3.50% 148.85 19:00:00
Open Price Low Price High Price Close Price Previous Close
150.00 146.94 155.055 148.85 154.25
more quote information »

Recent News

Date Time Source Heading
5/28/202407:00GLOBEBriaCell Announces Clinical Supply Agreement with BeiGene..
5/24/202405:00BWBRUKINSA® Data at ASCO Underscore Differentiated Clinical..
5/15/202417:10BWEHA2024: BeiGene präsentiert neues Hämatologie-Portfolio und..
5/15/202416:50BWBeiGene présente de nouvelles données de portefeuille et de..
5/14/202415:01BWBeiGene Highlights New Hematology Portfolio and Pipeline..
5/09/202414:03BWBeiGene meldet Finanzergebnisse für das erste Quartal 2024..
5/09/202408:38BWベイジーン、2024年第1四半期決算および事業に関する最新情報を発表
5/08/202420:02BWBeiGene公布2024年第一季財務業績和最新業務情況
5/08/202418:03BWBeiGene présente ses résultats financiers du premier..
5/08/202405:00BWBeiGene Reports First Quarter 2024 Financial Results and..
4/26/202409:34BWBeiGene Demonstrates Global Progress in 2023 Responsible..
4/25/202406:11BWGlobaler Onkologie-Innovator BeiGene präsentiert auf der..
4/25/202406:10BWBeiGene, innovateur mondial en oncologie, présente de..
4/24/202415:01BWGlobal Oncology Innovator BeiGene Highlights New Data across..
4/23/202418:31BWBeiGene erhält von der EU-Kommission die Zulassung für..
4/23/202405:00BWBeiGene Receives European Commission Approval for..
3/16/202410:18BWBeiGene、化学療法後の進行性または転移性食道扁平上皮癌の治療のためのTEVIMBRA®のFDA承認取得
3/15/202416:13BW百濟神州喜獲FDA批准,TEVIMBRA®將用於晚期或轉移性食管鱗狀細胞癌在化療後的治療
3/15/202415:02BWBeiGene reçoit l'approbation de la FDA pour TEVIMBRA® dans..
3/15/202401:06BWBeiGene erhält FDA-Zulassung für TEVIMBRA ® zur Behandlung..
3/14/202415:28BWBeiGene Receives FDA Approval for TEVIMBRA® for the..
3/14/202409:23BWマックス財団、ベイジーン、ベイジーン財団の協力により、低・中所得国の慢性リンパ性白血病患者にBRUKINSA®を初回投与
3/14/202404:31BWThe Max Foundation、BeiGene和BeiGene..
3/13/202414:01BWErste Dosen von BRUKINSA ® für Patienten mit chronischer..
3/13/202407:00BWFirst Doses of BRUKINSA® provided to Patients with Chronic..
3/07/202416:19BWBeiGene Announces FDA Accelerated Approval of BRUKINSA for..
3/06/202405:00BWBeiGene to Present Clinical and Preclinical Data from Broad..
2/29/202410:17BWベイジーン、2023年第4・四半期および通期決算と事業に関する最新情報を発表
2/29/202409:00BWBeiGene Announces New Efficacy Analysis Comparing BRUKINSA®..
2/28/202418:56BWBeiGene publie ses résultats financiers du quatrième..
2/28/202412:13BWBeiGene meldet Finanzergebnisse für das vierte Quartal und..
2/28/202407:05BWBeiGene to Present at Upcoming Investor Conferences
2/28/202406:43BWベイジーン、非小細胞肺がん治療薬チスレリズマブに対してCHMPから肯定的意見を受領
2/28/202405:48BWBeiGene公布2023年第四季及全年財務業績和最新業務情況
2/27/202406:24BW百濟神州(BeiGene)獲得 CHMP 對替雷利珠單抗(Tislelizumab)治療非小細胞肺癌的積極意見
2/27/202406:22BWBeiGene erhält positives CHMP-Gutachten für Tislelizumab zur..
2/27/202405:00BWBeiGene’s Biologics License Application for TEVIMBRA®..
2/26/202405:02EDGAR2Form 8-K - Current report
2/26/202405:00BWBeiGene Reports Fourth Quarter and Full Year 2023 Financial..
2/26/202404:00BWBeiGene Receives Positive CHMP Opinion for Tislelizumab as..
2/07/202405:47PRNCASanté Canada approuve BRUKINSA® (zanubrutinib) dans le..
1/31/202405:47PRNCAAdults living with chronic lymphocytic leukemia (CLL) in..
1/24/202413:03BWベイジーン、取締役会に経験豊富なライフサイエンス界のエグゼクティブ、オリビエ・ブランディクールを迎える
1/23/202411:04BWBeiGene accueille au sein de son conseil d'administration,..
1/23/202410:55BWBeiGene heißt den erfahrenen Life Sciences Manager Olivier..
1/23/202405:03EDGAR2Form 8-K - Current report
1/23/202405:00BWBeiGene Welcomes Experienced Life Sciences Executive Olivier..
12/22/202305:00BWFDA Approves Label Update for BRUKINSA® (zanubrutinib) in..
12/21/202305:01BWBeiGene to Present at the 42nd Annual J.P. Morgan Healthcare..
11/29/202315:01BWBeiGene to Host ASH Investor Meeting in Person and via..

Your Recent History

Delayed Upgrade Clock